XBI
SPDR® S&P Biotech ETF
S&P Biotechnology Select Industry TR USD
NAV as of
4 Week: 73.13 - 83.59
52 Week: 62.81 - 96.09
Latest Closing Price
74.19
Premium / Discount
-0.07
Expense Ratio
0.35%
Investment Objective
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").
Main Fund Characteristics
Performance
| Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
|---|---|---|---|
| YTD | -10.61 | 1.86 | -5.70 |
| 1 Day | 0.64 | 0.00 | 0.00 |
| 1 Week | -3.02 | 4.38 | -0.69 |
| 1 Month | -8.94 | 8.39 | -1.07 |
| 3 Months | -8.27 | 15.29 | -0.54 |
| 6 Months | -3.21 | 24.18 | -0.13 |
| 1 Year | -19.16 | 42.77 | -0.45 |
| 2 Years | -43.55 | 54.32 | -0.80 |
| 3 Years | -0.05 | 65.36 | -0.00 |
| 5 Years | -16.26 | 80.37 | -0.20 |
| 10 Years | -24.79 | 152.63 | -0.16 |
Price History
Annual Performance Return
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
| Price (%) | 48.5056 | 44.6682 | 13.6064 | -15.4372 | 43.6993 | -14.9021 | 32.2006 | 48.1873 | -20.5308 | -25.7573 |
| Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
| Rank | 47.0000 | 1.0000 | 5.0000 | 76.0000 | 8.0000 | 96.0000 | 19.0000 | 12.0000 | 98.0000 | 79.0000 |
Dividend Frequency
Lastest Dividend
| Ex Date | Payment Date | Dividend Payout per unit |
|---|---|---|
| 15/12/2016 | 26/12/2016 | 0.0183 |
| 16/06/2016 | 26/06/2016 | 0.0455 |
| 18/12/2014 | 29/12/2014 | 0.4910 |
| 18/09/2014 | 28/09/2014 | 0.5628 |
| 19/06/2014 | 29/06/2014 | 0.6161 |
| 20/03/2014 | 30/03/2014 | 0.3330 |
| 19/12/2013 | 30/12/2013 | 0.0378 |
| 19/09/2013 | 30/10/2013 | 0.0873 |
| 20/06/2013 | 30/06/2013 | 0.0516 |
| 14/03/2013 | 24/03/2013 | 0.0440 |
Portfolio Data
Total Number of Holdings: 150
Number of Bond Holdings: 0
Number of Equity Holdings: 147
Total Market Value: 6,489,889,798
Portfolio Composition
Top 10 Holdings
| % Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals Inc | 3.3880 | 897,206 | -3,583 | 216,800,858 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
| Size | % of portfolio |
|---|---|
| Giant | 1.06 |
| Large | 6.41 |
| Medium | 13.92 |
| Small | 32.19 |
| Micro | 46.61 |
Equity Style Box Breakdown
| 0 | 0 | 0 | Large |
| 0 | 0 | 0 | Mid |
| 0 | 0 | 0 | Small |
| Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
10.6538
Price/Book*
2.9247
Price/Sales*
2.1595
Price/Cash Flow*
7.7614
Dividend Yield*
0.1258
Growth Measures
Long-Term Earnings
14.5236
Historical Earnings
15.6905
Sales Growth
23.9747
Cash-Flow Growth
-1.3327
Book-Value Growth
-7.6198
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
| Detail | Value |
|---|---|
| Average Effective Duration | 0 |
| Average Effective Maturity (Years)* | 0 |
| Average Credit Quality | 0 |
| Average Weighted Coupon* | 0 |
| Average Weighted Price* | 0 |
Bond Style Box Breakdown
| 0 | 0 | 0 | High | Quality |
| 0 | 0 | 0 | Med | |
| 0 | 0 | 0 | Low | |
| Ltd | Mod | Ext | ||
| Interest-Rate Sensitivity | ||||
Credit Quality
| Type | % Bonds |
|---|---|
| N.A | |
Bond Sector
Bond Maturity
| % Bonds | |
|---|---|
| N.A | |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.
